Literature DB >> 15568615

Differential effects of CD28 costimulation upon cytokine production by CD4+ and CD8+ T cells.

Rosemary Rochford1, James E Riggs, Anaira Clavo, David N Ernst, Monte V Hobbs.   

Abstract

The impact of CD28 ligation upon CD4+ and CD8+ T lymphocyte proliferation and cytokine production was assessed. Although costimulation increased the proliferative response of both T cell subsets, cytokine production was most markedly increased in the CD4+ subset, as evidenced by a 40-fold increase in interleukin-2 (IL-2), a 14-fold increase in interleukin-3 (IL-3) and 5-fold increases in interferon gamma and GM-colony-stimulating factor (CSF) production. The CD8+ T cell response to CD28 ligation was less marked, maxima being a 5-fold increase in IL-2 production and 2-fold increases in IL-3 and GM-CSF production. Resolution of CD4+ and CD8+ T cells into their CD44lo (naïve) and CD44hi (memory/effector) subsets revealed that naive CD4+ T cells were the most CD28-responsive subsets. CD28-mediated costimulation promotes distinct differentiation programs in CD4+ versus CD8+ T cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15568615     DOI: 10.1016/j.imbio.2004.05.004

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  5 in total

1.  Peritoneal macrophages suppress T-cell activation by amino acid catabolism.

Authors:  R Matlack; K Yeh; L Rosini; D Gonzalez; J Taylor; D Silberman; A Pennello; J Riggs
Journal:  Immunology       Date:  2006-03       Impact factor: 7.397

2.  CD28 ligation increases macrophage suppression of T-cell proliferation.

Authors:  Daniel Silberman; Amanda Bucknum; Thomas Bartlett; Gabriella Composto; Megan Kozlowski; Amanda Walker; Amy Werda; Jackelyn Cua; Arlene H Sharpe; John E Somerville; James E Riggs
Journal:  Cell Mol Immunol       Date:  2012-04-23       Impact factor: 11.530

3.  Cytokine treatment of macrophage suppression of T cell activation.

Authors:  Daniel Silberman; Amanda Bucknum; Megan Kozlowski; Robin Matlack; James Riggs
Journal:  Immunobiology       Date:  2009-02-26       Impact factor: 3.144

4.  The molecular immunology of mucositis: implications for evidence-based research in alternative and complementary palliative treatments.

Authors:  Francesco Chiappelli
Journal:  Evid Based Complement Alternat Med       Date:  2005-12       Impact factor: 2.629

5.  Antibody response to pneumococcal and influenza vaccination in patients with rheumatoid arthritis receiving abatacept.

Authors:  Rieke Alten; Clifton O Bingham; Stanley B Cohen; Jeffrey R Curtis; Sheila Kelly; Dennis Wong; Mark C Genovese
Journal:  BMC Musculoskelet Disord       Date:  2016-05-26       Impact factor: 2.362

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.